Bioasis is dedicated to delivering hope to patients suffering with neurological diseases and disorders. Our breakthrough science focuses on transporting medicines across the blood-brain barrier, providing a path to hundreds of previously untreatable diseases of the central nervous system.
Bioasis will be meeting with potential partners and investors at the BIO CEO Investor Conference from February 10–12 at the New York Marriott Marquis, New York, NY. We will be presenting at 10 A.M. ET on Monday, February 10 in the Ziegfeld Room on the Fourth Floor.
Bioasis will be presenting at the OTC Markets 2020 Virtual Investor Conference at 11:30 A.M. ET on Thursday, February 20. Please register or login at the Virtual Investor Conferences website to view the presentation.